Therakos Meet the Expert Session
Thursday, October 24th, 2024
18:00-18:30
Hall A
| AGENDA | |
|---|---|
| 18:00-18:15 | ECP and Ruxolitinib combination in severe steroid-refractory acute GvHD Prof. Nicolaus Kröger, University Medical Center Hamburg-Eppendorf, Germany |
| 18:15-18:20 | Q&A |
| 18:20-18:30 | Announcement of the winner of the Mallinckrodt 2024 Advancing ECP Immunomodulation Investigator Award: 30 Years of ECP in Graft versus Host Disease. Refining THERAKOS ECP Immunomodulation™ |
ECP: Extracorporeal Photopheresis, GvHD: Graft versus Host Disease
